Panbela Therapeutics Inc (PBLA)

$0.20 -0.05 (-19.36%)
Market Cap 1.22M
Revenue (ttm) 0.00
Net Income (ttm) -25.26M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio -0.23
Volume 5,300
Avg Vol 14,562
Day's Range N/A - N/A
Shares Out 4.86M
Stochastic %K 2%
Beta 1.35
Analysts Strong Sell
Price Target $25.00

Company Profile

Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of disruptive therapeutics for the treatment of patients with urgent unmet medical needs. The company's lead product candidates are Ivospemin (SBP-101), a proprietary polyamine analogue, which has completed Phase Ia/Ib clinical trial for the treatment of patients with metastatic pancreatic ductal adenocarcinoma; Flynpovi, a combination of eflornithine (CPP-1X) and sulindac which is in Phase III cli...

Industry: Biotechnology
Sector: Healthcare
Phone: 952 479 1196
Address:
712 Vista Boulevard, Suite 305, Waconia, United States
Komba
Komba Jun. 18 at 6:15 PM
$PBLA keep an eye on BTOG. Will pump, low float, being held down. Great entrance, great play.!
0 · Reply
YasirTrades
YasirTrades Jun. 18 at 2:15 PM
GLMD is a ticking time bomb 💣 Trading under cash. $20+ book. No debt. Tiny float. GLP-1 catalyst loading. Chart is coiled tight. When volume hits… boom 💥 100%+ upside? That might be conservative. $ATNF, $MEGL, $PBLA, $HCDI
0 · Reply
SilentRider1
SilentRider1 May. 22 at 9:31 PM
$PBLA or noway
0 · Reply
SilentRider1
SilentRider1 May. 16 at 10:58 AM
$PBLA its very low float...few millions share , it could be a huge bo for few bucks or less a share
0 · Reply
EVOTZ
EVOTZ May. 16 at 12:03 AM
$PBLA still no ASPIRE PR and we are 6 weeks past Q1. Still no year end sec filing for 2024. CEO and CFO not responding to calls/texts. Pulling the plug or big pharma buyout??? It’s too quiet
0 · Reply
NVDAMillionaire
NVDAMillionaire Mar. 27 at 10:10 AM
$PBLA Polyamine pathway looks promising. ASPIRE trial could be game-changer for pancreatic cancer treatment. Watching closely for Q1 interim data. strong article: https://beyondspx.com/article/panbela-therapeutics-otcqb-pbla-pioneering-polyamine-pathway-modulation-in-the-fight-against-cancer
0 · Reply
EVOTZ
EVOTZ Mar. 12 at 1:24 PM
$PBLA ASPIRE data any day now. Potentially a huge PR
0 · Reply
zeph1985
zeph1985 Feb. 7 at 4:42 PM
$PBLA MTNB looks good,,,
1 · Reply
Miok
Miok Jan. 21 at 4:15 PM
$PBLA holding patiently..
0 · Reply
EVOTZ
EVOTZ Jan. 11 at 10:03 PM
$PBLA potential for a huge upswing this quarter. They will be reporting interim data from ASPIRE trial.
0 · Reply
Latest News on PBLA
No data available.
Komba
Komba Jun. 18 at 6:15 PM
$PBLA keep an eye on BTOG. Will pump, low float, being held down. Great entrance, great play.!
0 · Reply
YasirTrades
YasirTrades Jun. 18 at 2:15 PM
GLMD is a ticking time bomb 💣 Trading under cash. $20+ book. No debt. Tiny float. GLP-1 catalyst loading. Chart is coiled tight. When volume hits… boom 💥 100%+ upside? That might be conservative. $ATNF, $MEGL, $PBLA, $HCDI
0 · Reply
SilentRider1
SilentRider1 May. 22 at 9:31 PM
$PBLA or noway
0 · Reply
SilentRider1
SilentRider1 May. 16 at 10:58 AM
$PBLA its very low float...few millions share , it could be a huge bo for few bucks or less a share
0 · Reply
EVOTZ
EVOTZ May. 16 at 12:03 AM
$PBLA still no ASPIRE PR and we are 6 weeks past Q1. Still no year end sec filing for 2024. CEO and CFO not responding to calls/texts. Pulling the plug or big pharma buyout??? It’s too quiet
0 · Reply
NVDAMillionaire
NVDAMillionaire Mar. 27 at 10:10 AM
$PBLA Polyamine pathway looks promising. ASPIRE trial could be game-changer for pancreatic cancer treatment. Watching closely for Q1 interim data. strong article: https://beyondspx.com/article/panbela-therapeutics-otcqb-pbla-pioneering-polyamine-pathway-modulation-in-the-fight-against-cancer
0 · Reply
EVOTZ
EVOTZ Mar. 12 at 1:24 PM
$PBLA ASPIRE data any day now. Potentially a huge PR
0 · Reply
zeph1985
zeph1985 Feb. 7 at 4:42 PM
$PBLA MTNB looks good,,,
1 · Reply
Miok
Miok Jan. 21 at 4:15 PM
$PBLA holding patiently..
0 · Reply
EVOTZ
EVOTZ Jan. 11 at 10:03 PM
$PBLA potential for a huge upswing this quarter. They will be reporting interim data from ASPIRE trial.
0 · Reply
zeph1985
zeph1985 Jan. 7 at 10:29 PM
$PBLA MTNB gap filling.,.,..,.,.
0 · Reply
Miok
Miok Jan. 4 at 4:02 AM
$PBLA it suck webull cant trade this. money came late, got in on $.40s
0 · Reply
DNegs
DNegs Jan. 3 at 3:36 AM
$PBLA has been easy $ on bounces.
0 · Reply
AyyeeBihhh
AyyeeBihhh Jan. 2 at 2:43 PM
$PBLA 👀👀
0 · Reply
Foxger2
Foxger2 Jan. 1 at 7:33 PM
$PBLA
0 · Reply
Miok
Miok Dec. 25 at 1:17 AM
$PBLA Net loss in the quarter was approximately $7.2 million, or $1.48 per diluted share, compared to a net loss of $7.8 million, or $53.74 per diluted share, in the same period last year. Total current assets were $5.2 million and current liabilities were $20.1 million as of the same date. Interim analysis still on track for Q1 2025.
1 · Reply
Miok
Miok Dec. 14 at 1:27 AM
$PBLA setting up for Next Q.
0 · Reply
Miok
Miok Dec. 13 at 9:50 AM
$PBLA fused up to $9M from invester
0 · Reply
Miok
Miok Dec. 5 at 10:50 AM
$PBLA how is this still trading?
0 · Reply
NVDAMillionaire
NVDAMillionaire Dec. 4 at 9:29 AM
$PBLA Financials section https://beyondspx.com/article/panbela-therapeutics-inc-pbla-navigating-the-challenges-of-advancing-innovative-therapeutics
0 · Reply
CryptoSenderX
CryptoSenderX Oct. 31 at 10:23 AM
Primed to be the Next Pharma Big Mover $TCBP $AVXL $DRUG $STEC $PBLA
0 · Reply
DNegs
DNegs Oct. 30 at 11:21 PM
$PBLA this keep bouncing to .38….any big dips buy for the never ending .38 bounces.
0 · Reply